Author Archives: Patricia Inacio PhD

Soleno Therapeutics Presents Positive Data on DCCR, its Candidate Therapy for Prader-Willi Syndrome

Soleno Therapeutics presented data supporting the clinical benefits of its treatment candidate diazoxide choline controlled-release (DCCR) in patients with Prader-Willi syndrome (PWS). Specifically, researchers showed that DCCR reduces hyperphagia — an abnormally increased appetite and a hallmark of PWS — by triggering potassium channels in certain nerve cells. Moreover, DCCR was as…